During the last session, Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO)’s traded shares were 1.39 million. At the end of the trading day, the stock’s price was $1.58, reflecting an intraday gain of 19.70% or $0.26. The 52-week high for the CDIO share is $10.25, that puts it down -548.73 from that peak though still a striking 49.37% gain since the share price plummeted to a 52-week low of $0.80. The company’s market capitalization is $15.80M, and the average intraday trading volume over the past 10 days was 0.54 million shares, and the average trade volume was 3.51 million shares over the past three months.
Cardio Diagnostics Holdings Inc. (CDIO) received a consensus recommendation of a Buy from analysts. That translates to a mean rating of 2.00. CDIO has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be $0.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO) trade information
Cardio Diagnostics Holdings Inc. (CDIO) registered a 19.70% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 19.70% in intraday trading to $1.58 this Thursday, 05/25/23, hitting a weekly high. The stock’s 5-day price performance is 8.23%, and it has moved by -34.98% in 30 days. The short interest in Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO) is 0.11 million shares and it means that shorts have 0.73 day(s) to cover.
The consensus price target of analysts on Wall Street is $8.00, which implies an increase of 80.25% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8.00 and $8.00 respectively. As a result, CDIO is trading at a discount of -406.33% off the target high and -406.33% off the low.
Revenue for the current quarter is expected to be $400k as predicted by 1 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to $30k by the end of Mar 2023.
Cardio Diagnostics Holdings Inc. is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO)’s Major holders
Cardio Diagnostics Holdings Inc. insiders own 36.41% of total outstanding shares while institutional holders control 3.71%, with the float percentage being 5.83%. Linden Advisors LP is the largest shareholder of the company, while 15 institutions own stock in it. As of Mar 30, 2023, the company held over 85713.0 shares (or 0.86% of all shares), a total value of $0.34 million in shares.
The next largest institutional holding, with 74284.0 shares, is of Geode Capital Management, LLC’s that is approximately 0.74% of outstanding shares. At the market price on Mar 30, 2023, these shares were valued at $0.29 million.
Data provided on Feb 27, 2023 indicates that Fidelity Extended Market Index Fund owns about 63500.0 shares. This amounts to just over 0.66 percent of the company’s overall shares, with a $0.22 million market value.